 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTING LAW . 
        [Brackets ] indicate matter deleted from existing law.             *sb0247*      
SENATE BILL 247  
Q3, C8    6lr1292  
    CF 6lr1293  
By: Senator Beidle  
Introduced and read first time: January 16, 2026  
Assigned to: Budget and Taxation  
 
A BILL ENTITLED  
 
AN ACT concerning  1 
 
Biotechnology Investment Incentive Tax Credit – Conversion to Grant  Program  2 
 
FOR the purpose of  converting the Biotechnology Investment Incentive Tax Credit to be 3 
the Biotechnology Investment Incentive Grant Program in the De partment of 4 
Commerce; requiring the Department to disburse a grant within a certain time 5 
period; allowing a subtraction modification under the Mar yland income tax for 6 
certain grants received during the taxable year; and generally relating to the 7 
Biotechnol ogy Investment Incentive Grant Program.    8 
 
BY transferring  9 
 Article – Tax – General  10 
Section 10–725(a), (b), (c), (d) and (e), (f), (g), (h), and (i)  11 
 Annotated Code of Maryland  12 
 (2022 Replacement Volume and 2025 Supplement)  13 
to be  14 
 Article  – Economic Development  15 
Section  5–2701 , 5–2702, 5 –2703, 5 –2704, 5 –2706, 5 –2707, 5 –2708, and 5–2709 , 16 
respectively,  to be under the new subtitle “Subtitle 27. Biotechnology 17 
Investment Incentive Grant Program”  18 
 Annotated Code of Maryland  19 
 (2024 Replacement Vo lume and 2025 Supplement)  20 
 
BY repealing and reenacting, with amendments,  21 
 Article – Economic Development  22 
Section 2.5–109(a), 6–1001(b) , (c), and (e), and 6–1006  23 
 Annotated Code of Maryland  24 
 (2024 Replacement Volume and 2025 Supplement)  25 
 
BY repealing and re enacting, with amendments,  26 
 Article – Economic Development  27 
Section 5 –2701 through 5 –2704 and 5 –2706 through 5 –2709  28 
2 SENATE BILL 247   
 
  Annotated Code of Maryland  1 
 (2024 Replacement Volume and 2025 Supplement)  2 
 (As enacted by Section 1 of this Act)  3 
 
BY adding to  4 
 Article – Economic Development  5 
Section 5 –2705  6 
 Annotated Code of Maryland  7 
 (2024 Replacement Volume and 2025 Supplement)  8 
 
BY repealing and reenacting, without amendments,  9 
 Article – Economic Development  10 
Section 6 –1001(a)  and (d)  11 
 Annotated Code of Maryland  12 
 (2024 Replacement Volume and 2025 Supplement)  13 
 
BY repealing and reenacting, without amendments,  14 
 Article – Tax – General  15 
Section 10–207(a) and 10 –307(a)  16 
 Annotated Code of Maryland  17 
 (2022 Replacement Volume and 2025 Supplement)  18 
 
BY adding to  19 
 Article – Tax – General 20 
Section 10–207(rr) and 10 –307(h)  21 
 Annotated Code of Maryland  22 
 (2022 Replacement Volume and 2025 Supplement)  23 
 
BY repealing  24 
 Article – Tax – General  25 
 Section 10 –725(j)  26 
 Annotated Code of Maryland  27 
 (2022 Replacement Volume and 2025 Supplement)  28 
 
BY repealing and reenacting, with amendments,  29 
 Article – Tax – General  30 
Section 10 –804(j)(1)  31 
 Annotated Code of Maryland  32 
 (2022 Replacement Volume and 2025 Supplement)  33 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 34 
That Section (s) 10–725(a), (b), (c), (d) and (e), (f), (g), (h), and (i)  of Article – Tax – General  35 
of the Annotated Code of Maryland be transferred to be Section (s) 5–2701, 5 –2702, 5 –2703, 36 
5–2704, 5 –2706, 5 –2707, 5 –2708, and 5 –2709, respectively,  to be under the new subtitle 37 
“Subti tle 27. Biotechnology Investment Incentive Grant Program”  of Article – Economic 38 
Development  of the Annotated Code of Maryland.  39 
 
 SENATE BILL 247  3 
 
  SECTION 2. AND BE IT  FURTHER  ENACTED, That the Laws of Maryland read 1 
as follows:  2 
 
Article – Economic Development  3 
 
2.5–109. 4 
 
 (a) In this section, “economic development program” means:  5 
 
  (1) the Economic Development Opportunities Program Account 6 
established under § 7 –314 of the State Finance and Procurement Article;  7 
 
  (2) the Partnership for Workforce Quality Program established under Title 8 
3, Subtitle 4 of this article;  9 
 
  (3) each of the economic development and financial assistance programs 10 
established under Title 5 of this article; and  11 
 
  (4) each of the tax credit programs administered by the Department, 12 
including:  13 
 
   (i) the Film Production Activity Tax Credit;  14 
 
   (ii) the Job Creation Tax Credit;  15 
 
   (iii) the One Maryland Economic Development Tax Credit;  16 
 
   (iv) [the Biotechnology Investment Incentive Tax Credit;  17 
 
   (v)] the Research and Development Tax Credit;  18 
 
   [(vi)] (V) the Security Clearance Administrative Expenses and 19 
Construction and Equipment Costs Tax Credit;  20 
 
   [(vii)] (VI) the Innovation Investment Incentive Tax Credit;  21 
 
   [(viii)] (VII) the More Jobs for Marylanders Tax Credit;  22 
 
   [(ix)] (VIII) the Pu rchase of Cybersecurity Technology or Service Tax 23 
Credit;  24 
 
   [(x)] (IX) the Opportunity Zone Enhancement Tax Credit;  25 
 
   [(xi)] (X) the Small Business Relief Tax Credit;  26 
 
4 SENATE BILL 247   
 
    [(xii)] (XI) any other tax credit program that is administered by the 1 
Department under:  2 
 
    1. Title 6 of this article; or  3 
 
    2. Title 10, Subtitle 7 of the Tax – General Article; and  4 
 
   [(xiii)] (XII) the Theatrical Production Tax Credit.  5 
 
Subtitle 27. Biotechnology Investment Incentive Grant Program.  6 
 
5–2701.  7 
 
 (a) [(1)] In this [section ] SUBTITLE  the following words have the meanings 8 
indicated.  9 
 
  [(2)] (B) “Biotechnology company” means a company organized for profit 10 
that is primarily engaged in, or within 2 months will be primarily engaged in, the research, 11 
development, or commercialization of innovative and proprietary technology that 12 
comprises, interacts with, or analyzes biological material including biomolecules (DNA, 13 
RNA, or protein), cells, tissues, or organs.  14 
 
  [(3)] (C) [(i)] (1) “Company” means any entity of any fo rm duly 15 
organized and existing under the laws of any jurisdiction for the purpose of conducting 16 
business for profit.  17 
 
   [(ii)] (2) “Company” does not include a sole proprietorship.  18 
 
  [(4) “Department” means the Department of Commerce.  19 
 
  (5)] (D) “FUND” MEANS THE BIOTECHNOLOGY INVESTMENT 20 
INCENTIVE GRANT PROGRAM FUND. 21 
 
 (E) [(i)] (1) “Investment” means the contribution of money in cash or cash 22 
equivalents expressed in United States dollars, at a risk of loss, to a qualified Maryland 23 
biotechnology company i n exchange for stock, a partnership or membership interest, or 24 
other ownership interest in the equity of the qualified Maryland biotechnology company, 25 
title to which ownership interest shall vest in the qualified investor.  26 
 
   [(ii)] (2) “Investment” does not include debt.  27 
 
   [(iii)] (3) For purposes of this [section ] SUBTITLE , an investment is 28 
at risk of loss when its repayment entirely depends upon the success of the business 29 
operations of the qualified company.  30 
 
 SENATE BILL 247  5 
 
  (F) “PROGRAM ” MEANS THE BIOTECHNOLOGY INVESTMENT INCENTIVE 1 
GRANT PROGRAM . 2 
 
  [(6)] (G) [(i)] (1) “Qualified investor” means any individual or entity 3 
that invests at least $25,000 in a qualified Maryland biotechnology company and that is 4 
required to file an inc ome tax return in any jurisdiction.  5 
 
   [(ii)] (2) “Qualified investor” does not include:  6 
 
    [1.] (I) a qualified pension plan, individual retirement 7 
account, or other qualified retirement plan under the Employee Retirement Income 8 
Security Act of 1974, a s amended, or fiduciaries or custodians under such plans, or similar 9 
tax–favored plans or entities under the laws of other countries; or  10 
 
    [2.] (II) a founder or current employee of the qualified 11 
Maryland biotechnology company, if the company has been i n active business for more than 12 
5 years.  13 
 
  [(7)] (H) [(i)] (1) “Qualified Maryland biotechnology company” 14 
means a biotechnology company that:  15 
 
    [1.] (I) has its headquarters and base of operations in this 16 
State;  17 
 
    [2.] (II) has fewer than 50 full–time employees;  18 
 
    [3.] (III) has been in active business no longer than 12 years;  19 
 
    [4.] (IV) does not have its securities publicly traded on any 20 
exchange;  21 
 
    [5.] (V) has been certified as a biotechnology company by 22 
the Department; and  23 
 
    [6.] (VI) the qualified investors in the company have not 24 
received more than $7,000,000 in tax credits UNDER THE BIOTECHNOLOGY 25 
INVESTMENT INCENTIVE TAX CREDIT PROGRAM OR GRANTS in the aggregate under 26 
this [section ] SUBTITLE . 27 
 
   [(ii)] (2) “Qualified Maryla nd biotechnology company” includes a 28 
company that, within 2 months of the receipt of the investment, has met the requirements 29 
of [subparagraph (i) of this paragraph ] PARAGRAPH (1) OF THIS SUBSECTION . 30 
 
  [(8) “Secretary” means the Secretary of Commerce. ] 31 
 
6 SENATE BILL 247   
 
 5–2702.  1 
 
 [(b)] (A) (1) THERE IS A BIOTECHNOLOGY INVESTMENT INCENTIVE 2 
GRANT PROGRAM IN THE DEPARTMENT . 3 
 
  (2) THE PROGRAM IS THE SUCCES SOR TO THE BIOTECHNOLOGY 4 
INVESTMENT INCENTIVE TAX CREDIT  PROGRAM . 5 
 
  [(1)] (B) The [Biotechnology Investment Incentive Ta x Credit is 6 
intended ] PURPOSE OF THE PROGRAM IS to foster the growth of Maryland’s 7 
biotechnology industry by incentivizing investment in early stage companies with the goal 8 
of increasing the number of companies developing biotechnologies in Maryland, incre asing 9 
overall investments in the biotechnology sector, and increasing the number of individual 10 
investors actively investing in Maryland’s life sciences companies.  11 
 
  [(2)] (C) Subject to [paragraphs (3) and (4) of this subsection and ] 12 
subsections (d) and ( e) of this section  AND §§ 5–2704  AND 5–2705  OF THIS SUBTITLE , for 13 
the [taxable ] FISCAL  year in which an investment in a qualified Maryland biotechnology 14 
company is made, a qualified investor may [claim a credit against the State income tax  in 15 
an amount equal to the amount of tax credit stated in the final credit certificate approved 16 
by the Secretary ] BE AWARDED A GRANT B Y THE SECRETARY  for the investment as 17 
provided under this [section ] SUBTITLE . 18 
 
  [(3)] (D) To be eligible for [the tax credit described in paragraph (2) of this 19 
subsection ] A GRANT UNDER THIS S UBTITLE , the qualified investor shall be:  20 
 
   [(i)] (1) for a company, duly organized and in good standing in the 21 
jurisdiction under the laws under which it is organized;  22 
 
   [(ii)] (2) for a company , in good standing and authorized or 23 
registered to do business in the State;  24 
 
   [(iii)] (3) current in the payment of all tax obligations to the State 25 
or any unit or subdivision of the State; and  26 
 
   [(iv)] (4) not in default under the terms of any contra ct with, 27 
indebtedness to, or grant from the State or any unit or subdivision of the State.  28 
 
  [(4)] (E) To be eligible for [the tax credit described in paragraph (2) of this 29 
subsection ] A GRANT UNDER THIS S UBTITLE , the qualified investor may not, after 30 
making the proposed investment, own or control more than 25% of the equity interests in 31 
the qualified Maryland biotechnology company in which the investment is to be made.  32 
 
5–2703.  33 
 
 SENATE BILL 247  7 
 
  [(c)] (A) [(1)] At least 30 days prior to making an investment in a qualified 1 
Maryland biotechnology company for which a qualified investor would be eligible for an 2 
initial [tax credit ] GRANT  ELIGIBILITY  certificate under [subsection (b) of this section ] 3 
THIS SUBTITLE , the qualified investor shall submit an application to the Department.  4 
 
  [(2)] (B) The application shall evidence that the qualified Maryland 5 
biotechnology company is:  6 
 
   [(i)] (1) in good standing;  7 
 
   [(ii)] (2) current in the payment of all tax obligatio ns to the State 8 
or any unit or subdivision of the State; and  9 
 
   [(iii)] (3) not in default under the terms of any contract with, 10 
indebtedness to, or grant from the State or any unit or subdivision of the State.  11 
 
  [(3)] (C) [(i)] (1) Subject to [subparagraph (ii) of this paragraph ] 12 
PARAGRAPH (2) OF THIS SUBSECTION , the Department shall:  13 
 
    [1.] (I) approve all applications that qualify for [credits ] A 14 
GRANT  under this [section ] SUBTITLE  on a first –come, first –served basis; and  15 
 
    [2.] (II) within 30 days of receipt of an application, [certify 16 
the amount of any approved tax credits ] ISSUE AN INITIAL GRANT ELIGIBILITY 17 
CERTIFICAT E to a qualified investor.  18 
 
   [(ii)] (2) The Department may not issue any [tax credit certificates ] 19 
GRANTS  under this [section ] SUBTITLE  after June 30, 2028.  20 
 
  [(4)] (D) [(i)] (1) After the date on which the Department issues an 21 
initial [tax credit ] GRANT  ELIGIBILITY  certificate under this [section ] SUBTITLE , a 22 
qualified investor shall have 30 calendar days to make an investment in a qualified 23 
Maryland biotechnology company under this [section ] SUBTITLE . 24 
 
   [(ii)] (2) Within 10 calendar days after the date on which a 25 
qualified investor makes the investment, the qualified investor shall provide to the 26 
Department notice and proof of the making of the investment, including:  27 
 
    [1.] (I) the date of the investment;  28 
 
    [2.] (II) the amount invested;  29 
 
    [3.] (III) proof of the receipt of the invested funds by the 30 
qualified Maryland biotechnology company;  31 
 
8 SENATE BILL 247   
 
     [4.] (IV) a complete description of the nature of the 1 
ownership interest in the equity of the qualified Maryland biotechnology company acquired 2 
in consideration of the investment; and  3 
 
    [5.] (V) any reasonable supporting documentation the 4 
Department may require.  5 
 
   [(iii)] (3) If a qualified investor does not provide the notice and proof 6 
of the making of the investment required in [subparagraph (ii) of this paragraph ] 7 
PARAGRAPH  (2) OF THIS SUB SECTION  within 40 calendar days after the date on which 8 
the Department issues an initial [tax credit ] GRANT  ELIGIBILITY  certificate under this 9 
[section ] SUBTITLE : 10 
 
    [1.] (I) the Department shall rescind the initial [tax credit ] 11 
GRANT  ELIGIBILITY  certificate; a nd 12 
 
    [2.] (II) the [credit ] GRANT  amount allocated to the 13 
rescinded certificate shall [revert to the Maryland Biotechnology Investment Tax Credit 14 
Reserve Fund and shall ] be available in the applicable fiscal year for allocation by the 15 
Department to othe r initial [tax credit ] GRANT ELIGIBILITY  certificates in accordance 16 
with the provisions of this [section ] SUBTITLE . 17 
 
5–2704.  18 
 
 [(d)] (A) [(1) The tax credit ] SUBJECT TO SUBSECTION  (B) OF THIS 19 
SECTION , THE  GRANT  allowed in an initial [tax credit ] GRANT  ELIGIBILITY  certificate 20 
issued under this [section ] SUBTITLE  is: 21 
 
   [(i)] (1) except as provided in item [(ii) of this paragraph ] (2) OF 22 
THIS SUBSECTION , 33% of the investment in a qualified Maryland biotechnology company, 23 
not to exceed $250,000; or  24 
 
   [(ii)] (2) 50% of the investment in the qualified Maryland 25 
biotechnology company, not to exceed $500,000, if a qualified Maryland biotechnology 26 
company:  27 
 
    [1.] (I) is located in Allegany County, Dorchester County, 28 
Garrett County, or Somerset County; or  29 
 
    [2.] (II) is located in a Regional Institution Strategic 30 
Enterprise zone that is designated under [Title 5, ] Subtitle 14 of [the Economic 31 
Development Article ] THIS TITLE , is based on technology that was developed at a qualified 32 
institution within that  zone, and has been in active business not longer than 7 years.  33 
 
 SENATE BILL 247  9 
 
   [(2)] (B) During any fiscal year, the Secretary may not certify eligibility 1 
for [tax credits ] GRANTS  for investments in a single qualified Maryland biotechnology 2 
company that in the aggrega te exceed 10% of the total appropriations to the [Maryland 3 
Biotechnology Investment Tax Credit Reserve ] Fund for that fiscal year.  4 
 
  [(3) If the tax credit allowed under this section in any taxable year exceeds 5 
the total tax otherwise payable by the quali fied investor for that taxable year, the qualified 6 
investor may claim a refund in the amount of the excess.  7 
 
 (e) (1) In this subsection, “Reserve Fund” means the Maryland Biotechnology 8 
Investment Tax Credit Reserve Fund established under paragraph (2) of this subsection.  9 
 
  (2) (i) There is a Biotechnology Investment Tax Credit Reserve Fund 10 
which is a special continuing, nonlapsing fund that is not subject to § 7 –302 of the State 11 
Finance and Procurement Article.  12 
 
   (ii) The money in the Fund shall be inve sted and reinvested by the 13 
Treasurer, and interest and earnings shall be credited to the General Fund. ] 14 
 
  [(3)] (C) [(i)] (1) Subject to the provisions of this [subsection ] 15 
SECTION , the Secretary shall issue an initial [tax credit ] GRANT  ELIGIBILITY  certificate 16 
for each approved investment in a qualified Maryland biotechnology company eligible for a 17 
[tax credit ] GRANT . 18 
 
   [(ii)] (2) An initial [tax credit ] GRANT  ELIGIBILITY  certificate 19 
issued under this [subsection ] SECTION  shall state the maximum GRANT amount [of tax 20 
credit ] for which the qualified investor is eligible.  21 
 
   [(iii)] (3) [1.] (I) Except as otherwise provided in this 22 
[subparagraph ] PARAGRAPH , for any fiscal year, the Secretary may not issue initial [tax 23 
credit ] GRANT  ELIGIBILITY  certificates [for credit amounts ] in the aggregate totaling 24 
more than the amount appropriated to the [Reserve ] Fund for that fiscal year in the State 25 
budget as approved by the General Assembly.    26 
 
    [2.] (II) If the aggregate [credit ] GRANT  amounts unde r 27 
initial [tax credit ] GRANT  ELIGIBILITY  certificates issued in a fiscal year total less than 28 
the amount appropriated to the [Reserve ] Fund for that fiscal year, any excess amount 29 
shall remain in the [Reserve ] Fund and may be issued under initial [tax cred it] GRANT  30 
ELIGIBILITY  certificates for the next fiscal year.  31 
 
    [3.] (III) For any fiscal year, if funds are transferred from the 32 
[Reserve ] Fund under the authority of any provision of law [other than under paragraph 33 
(4) of this subsection ], the maximum [credit ] GRANT  amounts in the aggregate for which 34 
the Secretary may issue initial [tax credit ] GRANT  ELIGIBILITY  certificates shall be 35 
reduced by the amount transferred.  36 
10 SENATE BILL 247   
 
  
   [(iv) For each fiscal year, the Governor shall include in the budget bill 1 
an appropriation to the Reserve Fund.  2 
 
   (v) Notwithstanding the provisions of § 7 –213 of the State Finance 3 
and Procurement Article, the Governor may not reduce an appropriation to the Reserve 4 
Fund in the State budget as approved by the General Assembly. ] 5 
 
   [(vi)] (D) (1) Based on the actual amount of an investment made 6 
by a qualified investor  AS DOCUMENTED IN ACC ORDANCE WITH § 5–2703( D) OF THIS 7 
SUBTITLE , the Secretary shall [issue a final tax credit certificate ] AWARD A GRANT  to the 8 
qualified investor.  9 
 
  (2) THE DEPARTMENT SHALL DISB URSE THE GRANT TO THE 10 
QUALIFIED INVESTOR WITHIN 90 DAYS OF DETERMINING THAT THE  INVESTMENT 11 
HAS BEEN MADE . 12 
 
  [(4) (i) Except as provided in this paragraph, money appropriated to the 13 
Reserve Fund shall remain in the Fund.  14 
 
   (ii) 1. Within 15 days after the end of each calendar quarter, the 15 
Department shall notify the Comptroller as to each final credit certificate issued during the 16 
quarter:  17 
 
    A. the maximum credit amount stated in the initial tax credit 18 
certificate for the  investment; and  19 
 
    B. the final certified credit amount for the investment.  20 
 
    2. On notification that an investment has been certified, the 21 
Comptroller shall transfer an amount equal to the credit amount stated in the initial tax 22 
credit certificate f or the investment from the Reserve Fund to the General Fund. ] 23 
 
5–2705.  24 
 
 (A) THERE IS A BIOTECHNOLOGY INVESTMENT INCENTIVE GRANT 25 
PROGRAM FUND. 26 
 
 (B) THE DEPARTMENT SHALL ADMI NISTER THE FUND. 27 
 
 (C) (1) THE FUND IS A SPECIAL , NONLAPSING FUND THAT  IS NOT 28 
SUBJECT TO § 7–302 OF THE STATE FINANCE AND PROCUREMENT ARTICLE . 29 
 
  (2) THE STATE TREASURER SHALL HOLD THE FUND SEPARATELY , 30 
AND THE COMPTROLLER SHALL ACC OUNT FOR THE FUND. 31 
 SENATE BILL 247  11 
 
  
 (D) THE FUND CONSISTS OF : 1 
 
  (1) MONEY APPROPRIATED I N THE STATE BUDGET TO THE FUND;  2 
 
  (2) ANY GRANT AMOUNT THA T IS REVOKED UNDER T HIS SUBTITLE ; 3 
AND 4 
 
  (3) ANY OTHER MONEY FROM  ANY OTHER SOURCE ACC EPTED FOR 5 
THE BENEFIT OF THE FUND. 6 
 
 (E) THE FUND MAY BE USED ONLY  FOR GRANTS PROVIDED UNDER THIS 7 
SUBTITLE . 8 
 
 (F) (1) THE STATE TREASURER SHALL INVEST THE MON EY OF THE FUND 9 
IN THE SAME MANNER A S OTHER STATE MONEY MAY BE IN VESTED . 10 
 
  (2) ANY INTEREST EARNINGS  OF THE FUND SHALL BE CREDITE D TO 11 
THE GENERAL FUND OF THE STATE . 12 
 
 (G) EXPENDITURES FROM THE  FUND MAY BE MADE ONLY  IN ACCORDANCE 13 
WITH TH E STATE BUDGET . 14 
 
 (H) (1) FOR EACH FISCAL YEAR , THE GOVERNOR SHALL INCLUD E IN THE 15 
ANNUAL BUDGET BILL A N APPROPRIATION OF $10,000,000  TO THE FUND. 16 
 
  (2) NOTWITHSTANDING THE P ROVISIONS OF § 7–213 OF THE STATE 17 
FINANCE AND PROCUREMENT ARTICLE , THE GOVERNOR MA Y NOT REDUCE AN 18 
APPROPRIATION TO THE  FUND IN THE STATE BUDGET AS APPRO VED BY THE 19 
GENERAL ASSEMBLY . 20 
 
5–2706.  21 
 
 [(f)] (A) [(1)] The [credit claimed under this section ] GRANT PROVIDED 22 
UNDER THIS SUBTITLE shall be recaptured as provided in [paragraph (2) of this 23 
subsection ] SUBSECTION (B) OF THIS SECTION  if, within 2 years [from the close of the 24 
taxable year for which the credit is claimed ] AFTER THE GRANT WAS DISBURSED TO THE 25 
QUALIFIED INVESTOR : 26 
 
   [(i)] (1) the qualified investor sells, transfers, or other wise 27 
disposes of the ownership interest in the qualified Maryland biotechnology company that 28 
gave rise to the [credit ] GRANT ; or 29 
 
12 SENATE BILL 247   
 
    [(ii)] (2) the qualified Maryland biotechnology company that gave 1 
rise to the [credit ] GRANT  ceases  operating as an active business with its headquarters 2 
and base of operations in the State.  3 
 
  [(2)] (B) The amount required to be recaptured under this [subsection ] 4 
SECTION  is the product of multiplying:  5 
 
   [(i)] (1) the total amount of the [credit claimed ] DISBURSED 6 
GRANT  or, in the case of an event described in [paragraph (1)(i) of this subsection ] 7 
SUBSECTION (A)(1) OF THIS SECTION , the portion of the [credit ] DISBURSED GRANT  8 
attributable to the ownership interest disposed of; and  9 
 
   [(ii)] (2) [1.] (I) 100%, if the even t requiring recapture of the 10 
[credit occurs during the taxable year for which the tax credit is claimed ] DISBURSED 11 
GRANT OCCURS IN THE SAME FISCAL YEAR THA T THE GRANT WAS DISB URSED ; 12 
 
    [2.] (II) 67%, if the event requiring recapture of the [credit 13 
occurs  during the first year after the close of the taxable year for which the tax credit is 14 
claimed ] DISBURSED GRANT OCCU RS IN THE FISCAL YEAR AFTE R THE GRANT WAS 15 
DISBURSED ; or 16 
 
    [3.] (III) 33%, if the event requiring recapture of the [credit 17 
occurs more tha n 1 year but not more than 2 years after the close of the taxable year for 18 
which the tax credit is claimed ] DISBURSED GRANT OCCU RS IN THE SECOND FIS CAL 19 
YEAR AFTER THE GRANT  WAS DISBURSED . 20 
 
 (C) IF A COMPANY RECEIVES  AN INVESTMENT AND FA ILS TO SATISFY THE 21 
REQUIREMENTS FOR A Q UALIFIED MARYLAND BIOTECHNOLOG Y COMPANY WITHIN 22 
2 MONTHS  OF THE RECEIPT OF TH E INVESTMENT , THE DEPARTMENT SHALL REVO KE 23 
100%  OF THE  DISBURSED GRANT AMOU NT. 24 
 
  [(3)] (D) (1) The qualified investor that [claimed the credit ] HAS A 25 
DISBURSED GRANT THAT IS RECAPTURED UNDER THIS SECTION  shall pay the 26 
RECAPTURED  amount to [be recaptured as determined under paragraph (2) of this 27 
subsection as taxes payable to the State for the taxable year in which the event requiring 28 
recapture of the credit occur s] THE DEPARTMENT BY THE DAT E SET BY THE 29 
DEPARTMENT . 30 
 
  (2) THE DEPARTMENT SHALL DEPO SIT THE RECAPTURED AMOUNT 31 
INTO THE FUND. 32 
 
5–2707.  33 
 
 SENATE BILL 247  13 
 
  [(g)] (A) [(1)] The Department may revoke its initial [or final ] ELIGIBILITY  1 
certification  OR AWARD  of an approved [credit ] GRANT  under this [section ] SUBTITLE  if 2 
any representation in connection with the application for the certification is determined by 3 
the Department to have been false when made.  4 
 
  [(2)] (B) The revocation may be in full or in part as the Department may 5 
determine and, subject to [paragraph (3) of this subsection ] SUBSECTION (C) OF THIS 6 
SECTION , shall be communicated to the qualified investor [and the Comptroller ]. 7 
 
  [(3)] (C) The qualified in vestor shall have an opportunity to appeal any 8 
revocation to the Department [prior to notification of the Comptroller ]. 9 
 
  [(4) The Comptroller may make an assessment against the qualified 10 
investor to recapture any amount of tax credit that the qualified i nvestor has already 11 
claimed. ] 12 
 
5–2708.  13 
 
 [(h)] In accordance with § 2.5 –109 of [the Economic Development Article ] THIS 14 
ARTICLE , the Department shall report on the initial [tax credit ] ELIGIBILITY GRANT  15 
certificates awarded for the calendar year and the qualified Maryland biotechnology 16 
companies that received an investment for which an initial [tax credit ] ELIGIBILITY  17 
GRANT  certificate was awarded.  18 
 
5–2709.  19 
 
 [(i)] The Department [and the Comptroller jointly ] shall adopt regulations to carry 20 
out the provisions of this section and to specify criteria and procedures for application for, 21 
approval of, and monitoring continuing eligibility for the [tax credit under this section ] 22 
PROGRAM . 23 
 
6–1001.  24 
 
 (a) In this subtitle the following words have the meanings indicated.  25 
 
 (b) “Level 1 opportunity zone enhancement” means an enhanced tax credit OR 26 
GRANT  under the Program for which a qualified opportunity zone business or qualified 27 
opportunity fund is eligible if:  28 
 
  (1) the following information is provided to the Department:  29 
 
   (i) the date of the qualified opportunity fund’s investment in the 30 
qualified opportunity zone business and the amount of the investment;  31 
 
   (ii) the total project or business investment,  including any leverage;  32 
14 SENATE BILL 247   
 
  
   (iii) the address and census tract of the qualified opportunity zone 1 
business and the qualified opportunity fund;  2 
 
   (iv) the North American Industrial Classification System Code for 3 
the qualified opportunity zone business;  4 
 
   (v) an impact report, including both qualitative and quantitative 5 
data on the investment and, as applicable, its progress toward:  6 
 
    1. creating and retaining jobs;  7 
 
    2. promoting entrepreneurship, including among  8 
women – and minority –owned business es; 9 
 
    3. providing affordable housing;  10 
 
    4. creating access to healthy food;  11 
 
    5. promoting environmental sustainability; and  12 
 
    6. benefiting the communities in the opportunity zone in a 13 
manner not otherwise specified in this item; and  14 
 
   (vi) unless an applicant provides an affidavit to the Department 15 
along with the application that the qualified opportunity zone business property is 16 
unoccupied, will be demolished within 1 year of the date of the application, and will remain 17 
unoccupied until t he demolition is complete, with respect to qualified opportunity zone 18 
business property that is an affected property required to be registered with the 19 
Department of the Environment under § 6 –811 of the Environment Article:  20 
 
    1. proof of registration wi th the Department of the 21 
Environment;  22 
 
    2. if the property contains at least one residential rental unit, 23 
proof of lead inspections conducted in accordance with §§ 6 –815 and 6 –819 of the 24 
Environment Article;  25 
 
    3. if the property is an owner –occupied residential rental 26 
property:  27 
 
    A. proof that visual exterior or interior painted surfaces are 28 
free of chipping, flaking, or peeling lead –based paint; and  29 
 
    B. a copy of passing test results for lead –contaminated dust; 30 
and 31 
 
 SENATE BILL 247  15 
 
     4. verification that, f or the substantial improvement of the 1 
property performed in accordance with § 1400Z –2(d)(2)(D)(ii) of the Internal Revenue Code, 2 
replacement doors and windows are free of lead –based paint; and  3 
 
   (vii) any other information requested by the Department tha t meets 4 
the transparency goals of the Program; and  5 
 
  (2) for a qualified opportunity zone business located in an opportunity zone 6 
in a county with a minimum wage that exceeds the State minimum wage, the qualified 7 
opportunity zone business pays to each emp loyee wages that exceed the greater of:  8 
 
   (i) 120% of the State minimum wage; or  9 
 
   (ii) 120% of the county minimum wage.  10 
 
 (c) “Level 2 opportunity zone enhancement” means an enhanced tax credit  OR 11 
GRANT  under the Program for which a qualified opportunity zone business or qualified 12 
opportunity fund is eligible if:  13 
 
  (1) the requirements for a Level 1 opportunity zone enhancement are met;  14 
 
  (2) (i) accountability to residents of the communities in the op portunity 15 
zone is maintained through their representation on any governing board or advisory board 16 
of the qualified opportunity zone business; or  17 
 
   (ii) a community benefits agreement is negotiated and agreed to by 18 
community groups or strategic industry partnerships, as defined under § 11 –701 of the 19 
Labor and Employment Article, in the opportunity zone and the qualified opportunity fund 20 
that specifies a range of community benefits that the fund agrees to provide as part of the 21 
development project, includi ng workforce development or local hiring requirements; and  22 
 
  (3) (i) for a qualified opportunity zone business located entirely within 23 
an opportunity zone in a municipal corporation, the municipal corporation, by resolution or 24 
by letter, delivered to the Department by the municipal corporation’s authorized designee, 25 
approves the provision of the enhanced tax credits  OR GRANTS  under the Program within 26 
the municipal corporation; or  27 
 
   (ii) for a qualified opportunity zone business in an opportunity zone 28 
that is not located entirely within a municipal corporation, the county, by resolution or by 29 
letter, delivered to the Department by the county’s authorized designee, approves the 30 
provision of the enhanced tax credits  OR GRANTS  under the Program within the cou nty. 31 
 
 (d) “Opportunity zone” means an area that has been designated as a qualified 32 
opportunity zone in the State under § 1400Z –1 of the Internal Revenue Code.  33 
 
16 SENATE BILL 247   
 
  (e) “Program” means the Opportunity Zone Enhancement Program in the 1 
Department established und er § 6 –1002 of this subtitle that allows enhanced tax credits  2 
OR GRANTS  under:  3 
 
  (1) § 6–304 of this title (Job Creation);  4 
 
  (2) § 6–403 of this title (One Maryland economic development);  5 
 
  (3) § 10–702 of the Tax – General Article (wages paid in an ent erprise 6 
zone);  7 
 
  (4) [§ 10–725 of the Tax – General Article ] TITLE 5, SUBTITLE 27 OF 8 
THIS ARTICLE  (biotechnology investment incentive);  9 
 
  (5) § 10 –733 of the Tax – General Article (cybersecurity investment 10 
incentive); and  11 
 
  (6) § 10–741 of the Tax – General Article (More Jobs for Marylanders).  12 
 
6–1006.  13 
 
 (a) In this section, “investment”, “qualified investor”, and “qualified Maryland 14 
biotechnology company” have the meanings stated in [§ 10 –725 of the Tax – General 15 
Article ] § 5–2701  OF THIS ARTICLE . 16 
 
 (b) For a qualified opportunity fund that is a qualified investor in a qualified 17 
Maryland biotechnology company under [§ 10–725 of the Tax – General Article ] TITLE 5, 18 
SUBTITLE 27 OF THIS ARTICLE , if the qualified Maryland biotechnology company, on or 19 
after Ma rch 1, 2018, is newly established in or expands into an opportunity zone:  20 
 
  (1) the Level 1 opportunity zone enhancement is 65% of the investment in 21 
a qualified Maryland biotechnology company in any county, not to exceed $575,000; and  22 
 
  (2) the Level 2 o pportunity zone enhancement is 75% of the investment in 23 
the qualified Maryland biotechnology company in any county, not to exceed $750,000.  24 
 
 (c) The enhanced [tax credit ] GRANT  percentages and maximums authorized 25 
under subsection (b) of this section are i n substitution for and not in addition to the 26 
percentages and maximums under [§ 10–725(d) of the Tax – General Article ] TITLE 5, 27 
SUBTITLE 27 OF THIS ARTICLE . 28 
 
Article – Tax – General  29 
 
10–207. 30 
 
 SENATE BILL 247  17 
 
  (a) To the extent included in federal adjusted gross income, the amounts under 1 
this section are subtracted from the federal adjusted gross income of a resident to determine 2 
Maryland adjusted gross income.  3 
 
 (RR) THE SUBTRACTION UNDER  SUBSECTION (A) OF THIS SECTION INCL UDES 4 
THE AMOUNT OF A GRANT RECEIVED FROM  THE BIOTECHNOLOGY INVESTMENT 5 
INCENTIVE GRANT PROGRAM UNDER TITLE 5, SUBTITLE 27 OF THE ECONOMIC 6 
DEVELOPMENT ARTICLE . 7 
 
10–307. 8 
 
 (a) To the extent included in federal taxable income, the amounts under this 9 
section are subtracted from the federal taxable income of a corporation to determine 10 
Maryland modified income.  11 
 
 (H) THE SUBTRACTION UNDER  SUBSECTION (A) OF THIS SECTION INCL UDES 12 
THE AMOUNT OF A GRAN T RECEIVED FROM THE BIOTECHNOLOGY INVESTMENT 13 
INCENTIVE GRANT PROGRAM UNDER TITLE 5, SUBTITLE 27 OF THE ECONOMIC 14 
DEVELOPMENT ARTICLE .  15 
 
10–725. 16 
 
 [(j) If a company receives an investment under subsection (a)(7)(ii) of this section 17 
and fails to satisfy the requirements for a qualified Maryland biotechnology company 18 
within 2 months, the Department shall revoke any final tax credit certificates that have 19 
been issued and recapture any tax credits already claimed by the qualified investor. ] 20 
 
10–804. 21 
 
 (j) (1) Except as otherwise provided in this subsection, a taxpayer claiming 22 
any of the following tax credits shall submit a claim for the credit by electronic means as 23 
required by the Comptroller by regulation:  24 
 
   (i) the Job Creation Tax Credit, as provided under Title 6, Subtitle 25 
2 of the Economic Development Article;  26 
 
   (ii) the One Maryland Tax Credit, as provided under T itle 6, Subtitle 27 
4 of the Economic Development Article;  28 
 
   (iii) [the Biotechnology Investment Incentive Tax Credit, as provided 29 
under § 10 –725 of this title;  30 
 
   (iv)] the Enterprise Zone Income Tax Credit, as provided under §  31 
10–702 of this title; and  32 
 
18 SENATE BILL 247   
 
    [(v)] (IV) any other tax credit specified by the Comptroller through 1 
regulation.  2 
 
 SECTION 3. AND BE IT FURTHER ENACTED, That:  3 
 
 (a) The provisions of § 10 –725 of the Tax – General Article, as that section was in 4 
effect before the effective date of thi s Act, shall continue to apply to  tax credit certificate s 5 
issued under that section before the effective date of this Act.  6 
 
 (b) Title 5, Subtitle 27 of the Economic Development Article, as enacted by 7 
Section s 1 and 2  of this Act, shall apply to certificat es issued on or after the effective date 8 
of this Act.  9 
 
 SECTION 4. AND BE IT FURTHER ENACTED, That this Act shall take effect July 10 
1, 2026.  11 